210 related articles for article (PubMed ID: 23437196)
21. P70S6K 1 regulation of angiogenesis through VEGF and HIF-1alpha expression.
Bian CX; Shi Z; Meng Q; Jiang Y; Liu LZ; Jiang BH
Biochem Biophys Res Commun; 2010 Jul; 398(3):395-9. PubMed ID: 20599538
[TBL] [Abstract][Full Text] [Related]
22. MiR-203a-3p inhibits retinal angiogenesis and alleviates proliferative diabetic retinopathy in oxygen-induced retinopathy (OIR) rat model via targeting VEGFA and HIF-1α.
Han N; Xu H; Yu N; Wu Y; Yu L
Clin Exp Pharmacol Physiol; 2020 Jan; 47(1):85-94. PubMed ID: 31408201
[TBL] [Abstract][Full Text] [Related]
23. miR-6086 inhibits ovarian cancer angiogenesis by downregulating the OC2/VEGFA/EGFL6 axis.
Wu B; Zhang L; Yu Y; Lu T; Zhang Y; Zhu W; Song Q; Lv C; Guo J; Tian Y; Deng N
Cell Death Dis; 2020 May; 11(5):345. PubMed ID: 32393810
[TBL] [Abstract][Full Text] [Related]
24. Enhanced ROBO4 is mediated by up-regulation of HIF-1α/SP1 or reduction in miR-125b-5p/miR-146a-5p in diabetic retinopathy.
Gong Q; Xie J; Li Y; Liu Y; Su G
J Cell Mol Med; 2019 Jul; 23(7):4723-4737. PubMed ID: 31094072
[TBL] [Abstract][Full Text] [Related]
25. Overcoming cisplatin resistance in osteosarcoma through the miR-199a-modulated inhibition of HIF-1α.
Keremu A; Aini A; Maimaitirexiati Y; Liang Z; Aila P; Xierela P; Tusun A; Moming H; Yusufu A
Biosci Rep; 2019 Nov; 39(11):. PubMed ID: 28442599
[TBL] [Abstract][Full Text] [Related]
26. Suppression of tumor angiogenesis by metformin treatment via a mechanism linked to targeting of HER2/HIF-1α/VEGF secretion axis.
Wang J; Li G; Wang Y; Tang S; Sun X; Feng X; Li Y; Bao G; Li P; Mao X; Wang M; Liu P
Oncotarget; 2015 Dec; 6(42):44579-92. PubMed ID: 26625311
[TBL] [Abstract][Full Text] [Related]
27. Chronic arsenic exposure and angiogenesis in human bronchial epithelial cells via the ROS/miR-199a-5p/HIF-1α/COX-2 pathway.
He J; Wang M; Jiang Y; Chen Q; Xu S; Xu Q; Jiang BH; Liu LZ
Environ Health Perspect; 2014 Mar; 122(3):255-61. PubMed ID: 24413338
[TBL] [Abstract][Full Text] [Related]
28. LncRNA H19 promotes glioma angiogenesis through miR-138/HIF-1α/VEGF axis.
Liu ZZ; Tian YF; Wu H; Ouyang SY; Kuang WL
Neoplasma; 2020 Jan; 67(1):111-118. PubMed ID: 31777264
[TBL] [Abstract][Full Text] [Related]
29. Regulatory mechanism of lncRNA NORAD on proliferation and invasion of ovarian cancer cells through miR-199a-3p.
Xu C; Zhu LX; Sun DM; Yao H; Han DX
Eur Rev Med Pharmacol Sci; 2020 Feb; 24(4):1672-1681. PubMed ID: 32141533
[TBL] [Abstract][Full Text] [Related]
30. MicroRNA-497 suppresses angiogenesis by targeting vascular endothelial growth factor A through the PI3K/AKT and MAPK/ERK pathways in ovarian cancer.
Wang W; Ren F; Wu Q; Jiang D; Li H; Shi H
Oncol Rep; 2014 Nov; 32(5):2127-33. PubMed ID: 25176450
[TBL] [Abstract][Full Text] [Related]
31. Hypoxia-inducible factor-1α inhibition by a pyrrolopyrazine metabolite of oltipraz as a consequence of microRNAs 199a-5p and 20a induction.
Kang SG; Lee WH; Lee YH; Lee YS; Kim SG
Carcinogenesis; 2012 Mar; 33(3):661-9. PubMed ID: 22223846
[TBL] [Abstract][Full Text] [Related]
32. Long noncoding RNA LINC00152 promotes cell proliferation through competitively binding endogenous miR-125b with MCL-1 by regulating mitochondrial apoptosis pathways in ovarian cancer.
Chen P; Fang X; Xia B; Zhao Y; Li Q; Wu X
Cancer Med; 2018 Sep; 7(9):4530-4541. PubMed ID: 30030896
[TBL] [Abstract][Full Text] [Related]
33. LncRNA DLX6-AS1 increases the expression of HIF-1α and promotes the malignant phenotypes of nasopharyngeal carcinoma cells via targeting MiR-199a-5p.
Yang B; Jia L; Ren H; Jin C; Ren Q; Zhang H; Hu D; Zhang H; Hu L; Xie T
Mol Genet Genomic Med; 2020 Jan; 8(1):e1017. PubMed ID: 31782911
[TBL] [Abstract][Full Text] [Related]
34. Expression of miR-217 and HIF-1α/VEGF pathway in patients with diabetic foot ulcer and its effect on angiogenesis of diabetic foot ulcer rats.
Lin CJ; Lan YM; Ou MQ; Ji LQ; Lin SD
J Endocrinol Invest; 2019 Nov; 42(11):1307-1317. PubMed ID: 31079353
[TBL] [Abstract][Full Text] [Related]
35. Coordinate suppression of ERBB2 and ERBB3 by enforced expression of micro-RNA miR-125a or miR-125b.
Scott GK; Goga A; Bhaumik D; Berger CE; Sullivan CS; Benz CC
J Biol Chem; 2007 Jan; 282(2):1479-86. PubMed ID: 17110380
[TBL] [Abstract][Full Text] [Related]
36. MicroRNA-199a targets CD44 to suppress the tumorigenicity and multidrug resistance of ovarian cancer-initiating cells.
Cheng W; Liu T; Wan X; Gao Y; Wang H
FEBS J; 2012 Jun; 279(11):2047-59. PubMed ID: 22498306
[TBL] [Abstract][Full Text] [Related]
37. MicroRNA-145 inhibits the growth, invasion, metastasis and angiogenesis of neuroblastoma cells through targeting hypoxia-inducible factor 2 alpha.
Zhang H; Pu J; Qi T; Qi M; Yang C; Li S; Huang K; Zheng L; Tong Q
Oncogene; 2014 Jan; 33(3):387-97. PubMed ID: 23222716
[TBL] [Abstract][Full Text] [Related]
38. LncRNA TMPO-AS1 up-regulates the expression of HIF-1α and promotes the malignant phenotypes of retinoblastoma cells via sponging miR-199a-5p.
Peng X; Yan J; Cheng F
Pathol Res Pract; 2020 Apr; 216(4):152853. PubMed ID: 32139259
[TBL] [Abstract][Full Text] [Related]
39. microRNA-125b inhibits tube formation of blood vessels through translational suppression of VE-cadherin.
Muramatsu F; Kidoya H; Naito H; Sakimoto S; Takakura N
Oncogene; 2013 Jan; 32(4):414-21. PubMed ID: 22391569
[TBL] [Abstract][Full Text] [Related]
40. MicroRNA-206 attenuates the growth and angiogenesis in non-small cell lung cancer cells by blocking the 14-3-3ζ/STAT3/HIF-1α/VEGF signaling.
Xue D; Yang Y; Liu Y; Wang P; Dai Y; Liu Q; Chen L; Shen J; Ju H; Li Y; Tan Z
Oncotarget; 2016 Nov; 7(48):79805-79813. PubMed ID: 27806334
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
